I agree man. Just putting my 2 cents in. This thing can run easy being a pharma small cap. If they clear up toxic debt, this thing would be a juggernaut.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.